Rua Bioscience Limited — Share Issue/Capital Change 2023

Jun 1, 2023

Capital Change Notice

Section 1: Issuer information	Section 1: Issuer information
Name of issuer		Rua Bioscience Limited.
NZX ticker code		RUA
Class of financial product		Options to subscribe for Ordinary Shares in the Issuer (Options).
ISIN (If unknown, check on NZX website)		NZRUAE0004S1
Currency		NZD
Section 2: Capital change details
Number issue~~d~~	~~/acquired/redeemed~~	2,100,000
Nominal value	(if any)	Nil
Issue price per security		$0.00
Nature of the payment (for example, cash or other consideration)		Zero cash – provision of employment and personal services to the Issuer.
Amount paid up (if not in full)		N/A (as issued for no cash consideration).
Percentage of total class of Financial Products issue~~d/acquired/redeemed/~~(calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)1		1.33% (2dp) of the total number of Ordinary Shares on issue (undiluted).
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)		The Options will vest and convert into Ordinary Shares in the Issuer in a ratio of 1:1, for NIL cash consideration, on 3 June 2024 subject to conditions set out in Option Deeds for each Participant dated May 2023.
Reason for issu~~e/acquisition/redemption~~and specific authority for issu~~e/acquisition/redemption/~~(the reason for change must be identified here)		Consideration for services and performance incentive for employees (part of remuneration package)
Total number of Financial Products of the Class after the issu~~e/acquisition/redemption/Conversion~~(excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption.		Total number of Options of this class after the issue will be 4,550,000
In the case of an acquisition of shares, whether those shares are to be held as treasury stock		N/A

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Listing rule 4.6.1 and 4.11.1
Terms or details of the issu~~e, acquisition, or redemption~~(for example: restrictions, escrow arrangements)		Options vest and convert into Ordinary Shares on 3 June 2024 subject to conditions set out in Option Deeds for each Participant dated May 2023. Participant to pay associated tax liability.
Date of issue	/~~acquisition/redemption~~2	Grant date for the Options is 1 June 2023. Date for issue of the Ordinary Shares on conversion is 3 June 2024.
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement		Hamish White
Contact person for this announcement		Paul Naske
Contact phone number		021445154
Contact email address		Paul.naske@ruabio.com
Date of release through MAP		[01/06/2023]

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).